Sanjivani Paranteral Ltd Q1 FY26 earnings call summary

Earnings call of 12 Aug 2025, summarised by AI from the filing.

Sanjivani Paranteral Q1 FY26 revenue ₹17.9 cr, up 8.9%; guides FY26 revenue ₹75-80 cr and 15% EBITDA margin.

Key takeaways

1. Change SPL Infusion plant commercial production to start by end of August or first week of September.
2. Driver LATAM region is the growth driver for this year and next, with rapid growth in injectables.
3. Risk Logistics disruptions and container shortages impacted Q1 shipments; situation showing signs of easing.

Original filing on BSE

Sanjivani Paranteral Ltd earnings call, investor presentation and press release summaries

• Q1 FY27: Results deck (14 Aug 2026), Results press release (14 Aug 2026)
• Q4 FY26: Earnings call (15 May 2026), Results deck (14 May 2026)
• Q3 FY26: Earnings call (16 Feb 2026), Results deck (13 Jan 2026), Results press release (16 Feb 2026)
• Q2 FY26: Earnings call (19 Nov 2025), Results deck (18 Nov 2025), Results press release (15 Nov 2025)
• Q1 FY26: Earnings call (12 Aug 2025), Results deck (12 Aug 2025), Results press release (12 Aug 2025)
• Q4 FY25: Earnings call (27 May 2025), Results press release (27 May 2025)
• Q3 FY25: Results deck (27 Feb 2025)